US health advisers will consider Emergent BioSolutions's opioid overdose reversal drug for nonprescription sale, a move hoped to raise access amid the decades-long public-health crisis https://t.co/DOJWb6udno— Bloomberg (@business) February 15, 2023
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


